|
Pharmacology
Citations 151-160 of 165 total displayed.
|
Past content
(since Dec 2002):
|
- CLINICAL
Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients
- M. E. Mayerhoefer, J. Kramer, M. J. Breitenseher, C. Norden, A. Vakil-Adli, S. Hofmann, R. Meizer, H. Siedentop, F. Landsiedl, and N. Aigner
Rheumatology 2007; 46: 1460-1465.
[Abstract]
[Full Text]
- REVIEWS
Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability?
- K. Brune and D. E. Furst
Rheumatology 2007; 46: 911-919.
[Abstract]
[Full Text]
- REVIEWS
Chondroprotective drugs in degenerative joint diseases
- G. Verbruggen
Rheumatology 2006; 45: 129-138.
[Abstract]
[Full Text]
- REVIEWS
Pharmacokinetic–pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors
- D. R. H. Huntjens, M. Danhof, and O. E. Della Pasqua
Rheumatology 2005; 44: 846-859.
[Abstract]
[Full Text]
- REVIEWS
TNF-blocking agents and tuberculosis: new drugs illuminate an old topic
- J. Keane
Rheumatology 2005; 44: 714-720.
[Abstract]
[Full Text]
- REVIEWS
Leflunomide in rheumatoid arthritis: recommendations through a process of consensus
- P. Maddison, P. Kiely, B. Kirkham, T. Lawson, R. Moots, D. Proudfoot, R. Reece, D. Scott, R. Sword, A. Taggart, C. Thwaites, and E. Williams
Rheumatology 2005; 44: 280-286.
[Abstract]
[Full Text]
[ Supplementary data ]
- REVIEWS
Update on the British Society for Rheumatology guidelines for prescribing TNF blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
- J. Ledingham, and C. Deighton on behalf of the British Society for Rheumatology Standards, Guidelines and Audit Working Group
Rheumatology 2005; 44: 157-163.
[Extract]
[Full Text]
- REVIEWS
Assessment of patients with spondyloarthropathies for treatment with tumour necrosis factor blockade
- S. Paul and A. Keat
Rheumatology 2005; 44: 17-23.
[Extract]
[Full Text]
- REVIEWS
Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines
- R. Smith, L. Barnsley, S. Kannangara, and A. Mace
Rheumatology 2004; 43: 1473-1475.
[Abstract]
[Full Text]
- REVIEWS
Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives
- I. C. Chikanza and D. L. Kozaci
Rheumatology 2004; 43: 1337-1345.
[Extract]
[Full Text]
|
|
